000			02072 a2200577 4500
005			20250514015356.0
264		0	_c20011214
008			200112s 0 0 eng d
022			_a0268-3369
024	7		_a10.1038/sj.bmt.1703211 _2doi
040			_aNLM _beng _cNLM
100	1		_aOkano, A
245	0	0	_aSubcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation. _h[electronic resource]
260			_bBone marrow transplantation _cOct 2001
300			_a709-11 p. _bdigital
500			_aPublication Type: Case Reports; Journal Article; Review
650	0	4	_aAdult
650	0	4	_aBone Marrow Transplantation _xadverse effects
650	0	4	_aClarithromycin _xtherapeutic use
650	0	4	_aCombined Modality Therapy
650	0	4	_aCyclosporine _xadverse effects
650	0	4	_aDebridement
650	0	4	_aDrug Therapy, Combination _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aGraft vs Host Disease _xdrug therapy
650	0	4	_aHumans
650	0	4	_aImmunocompromised Host
650	0	4	_aImmunosuppressive Agents _xadverse effects
650	0	4	_aMethotrexate _xadverse effects
650	0	4	_aMinocycline _xtherapeutic use
650	0	4	_aMycobacterium Infections, Nontuberculous _xdrug therapy
650	0	4	_aMycobacterium fortuitum _xisolation & purification
650	0	4	_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _ximmunology
650	0	4	_aPrednisolone _xadverse effects
650	0	4	_aRemission Induction
650	0	4	_aSkin Ulcer _xdrug therapy
650	0	4	_aTacrolimus _xadverse effects
650	0	4	_aTransplantation Conditioning _xadverse effects
650	0	4	_aTransplantation, Homologous
700	1		_aShimazaki, C
700	1		_aOchiai, N
700	1		_aHatsuse, M
700	1		_aTakahashi, R
700	1		_aAshihara, E
700	1		_aInaba, T
700	1		_aFujita, N
700	1		_aNoda, Y
700	1		_aNakagawa, M
773	0		_tBone marrow transplantation _gvol. 28 _gno. 7 _gp. 709-11
856	4	0	_uhttps://doi.org/10.1038/sj.bmt.1703211 _zAvailable from publisher's website
999			_c11619832 _d11619832